Ruxolitinib induces changes in histone modification status in patients entered into the MAJIC clinical trial
Main Authors: | , , , , |
---|---|
其他作者: | |
格式: | Conference item |
出版: |
Wiley
2018
|
Main Authors: | , , , , |
---|---|
其他作者: | |
格式: | Conference item |
出版: |
Wiley
2018
|